Devyser receives the award for revolutionary solutions, extensive export investment and focus on correct diagnosis for each patient in the shortest possible time.
Ulf Klangby, deputy CEO and one of the company’s founders, received the award from the Minister of Social Affairs and Public Health Jacob Forssmed at a ceremony in Stockholm.
“We are incredibly proud to be recognized with this fine award,” says Fredrik Alpsten, CEO of Devyser. “We have had strong international growth in recent years, especially in Europe and Asia. Our investment in expanding direct sales in key markets has been highly successful. Now our focus is on the North American market. In June, we will inaugurate our new laboratory in Atlanta, Georgia, and earlier this week we presented a collaboration agreement with Thermo Fisher Scientific, an American company and world leader in the diagnostics industry. Through this partnership Thermo Fisher Scientific will market and sell, under combined brands, Devyser’s unique post-transplant follow-up NGS products in the US, Canada, and Europe, which means more patients can access better transplant care.”
Read more: The winner of the Swecare Rising Star Award
The “Swecare Export Award” has been awarded annually for more than 10 years. Out of five nominated companies, Devyser was named this year’s winner of the prestigious award. The jury consists of representatives from the life science industry and the Swedish government. The prize is awarded to companies that “with creativity, commitment and scope put Swedish innovation in health and healthcare on the world map”.
The nominated companies were Bactiguard, Devyser Diagnostics, Olink Proteomics och Zenicor Medical Systems.
The jury’s motivation to the Swecare Export Award 2023 was:
“The winner is a pioneer in advanced genetic testing, DNA diagnostics. The company is at the forefront of research in one of the areas that has the potential to revolutionize healthcare by enabling to identify and predict diseases early. Through the goal that every patient should receive a correct diagnosis in the shortest possible time, they contribute to a development with a focus on the patient and care provider with regard to sustainability and resources. From the beginning a research company that from the head office in Hägersten developed 29 different products that are now available in 50 countries. With intensive export investments in recent years, they have made a fantastic growth journey with great sales successes, where 92 percent of total sales are made up of export income.”
Image: Ulf Klangby, deputy CEO and co-founder Devyser received the award from the Minister of Social Affairs and Public Health Jakob Forssmed. Also in the photo, the winner of Swecare Rising Star Award, the CEO of AlgoDx, David Becedas